More on PRLD

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.0 Score)
- Holders

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Prelude Therapeutics Inc. (NQ:PRLD)
Delayed: 5.32 -0.17 (3.1%)
Prev. Close $5.49  
Open$5.53 
52 Wk High$ 
52 Wk Low$ 
Day High$5.82 
Day Low$5.30 
P/E N/A  
EPS$ 
Volume87,005 

Friends, Peers and Foes (?): ONCY, INCY, IMNM, ALXO, ERAS (more...)

Aug 11, 2026 08:06 AM Form 10-Q Prelude Therapeutics For: Jun 30
Aug 11, 2026 08:00 AM Form 8-K Prelude Therapeutics For: Aug 11
Aug 11, 2026 07:18 AM Prelude Therapeutics Incorporated (PRLD) Tops Q2 EPS by 9c
Aug 11, 2026 07:00 AM Prelude Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Jul 29, 2026 06:53 AM H.C. Wainwright Reiterates Buy Rating on Prelude Therapeutics (PRLD)
Jul 15, 2026 07:39 AM H.C. Wainwright Reiterates Buy Rating on Prelude Therapeutics (PRLD)
Jul 8, 2026 05:21 PM Form SCHEDULE 13G Prelude Therapeutics Filed by: Soleus Private Equity Fund III, L.P.
Jul 1, 2026 04:53 AM Prelude Therapeutics (PRLD) Reiterated at Market Outperform by Citizens
Jun 10, 2026 04:45 PM Form 4 Prelude Therapeutics For: Jun 09 Filed by: 667, L.P.
Jun 10, 2026 04:16 PM Form 4 Prelude Therapeutics For: Jun 09 Filed by: Dorton Katina
View All Articles

Entities mentioned with PRLD

View All Entities